Approval · Notice of Compliance 13031 · 2012
CO MYCOPHENOLATE: Notice of Compliance 13031
Issued February 13, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13031
- Date
- February 13, 2012
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Immunosuppresive AAgent
- Canadian reference product
- CELLCEPT (Hoffmann-La Roche Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CO MYCOPHENOLATE | 02379996 | Cancelled Post Market |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 500 MG per TAB